Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PULTEGROUP INC/MI/PHM · Entity 3207 | Director | February 21, 2018 | February 23, 2018 |
| SPX Technologies, Inc.SPXC · Entity 3543 | Director | May 12, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PULTEGROUP INC/MI/
Report date February 21, 2018 · Filed February 23, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 89,010 |
Ending reported balance
After 2018-02-21 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2018-02-21 · Exercise / conversion · Acquired 7,000 · Balance 90,687 Row 2 · 2018-02-21 · Sale · Disposed 4,561 · Balance 86,126 F1: The price reported is an average weighted price. These shares were sold in multiple transactions at prices ranging from $29.59 to $30.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Row 3 · 2018-02-21 · Exercise / conversion · Acquired 7,000 · Balance 93,126 Row 4 · 2018-02-21 · Sale · Disposed 4,116 · Balance 89,010 F1: The price reported is an average weighted price. These shares were sold in multiple transactions at prices ranging from $29.59 to $30.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.93 · Expires 2018-06-02 | Direct | 0 |
Reported balance
After 2018-02-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-02-21 · Exercise / conversion · Disposed 7,000 · Balance 0 |
| Director Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.85 · Expires 2019-06-02 | Direct | 0 |
Reported balance
After 2018-02-21 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-02-21 · Exercise / conversion · Disposed 7,000 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is an average weighted price. These shares were sold in multiple transactions at prices ranging from $29.59 to $30.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
SPX Technologies, Inc.
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,347 |
Reported balance
After 2026-05-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-12 · Grant · Acquired 754 · Balance 41,347 F1: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F2: Includes unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan.
F2: Includes unvested restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AVANOS MEDICAL, INC.
Report date July 27, 2026 · Filed July 28, 2026
Section 16 reporting ended · disclosed 2026-07-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-27 transaction · row 1
1 source rowRow 1 · 2026-07-27 · Disposition to issuer · Disposed 54,640 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-07-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-27 · Disposition to issuer · Disposed 12,003 · Balance 0 F2: Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. F3: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings). |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement.
F2: Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock.
F3: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2026 Filed Jul 28, 2026 21:37 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Disposition to issuerRestricted Share Units · Derivative | 12,003 | $25.00 | $300,075.00 |
DisclosureSEC source: 0001606498-26-000108 · wk-form4_1785274657.xml · derivative · entry 2 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,003 shares Expires not disclosed F2 · derivative.exercise_price: Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. F3 · price: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings). F3 · derivative.exercise_date: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings). F3 · derivative.expiration_date: Pursuant to the Merger Agreement, these cash-settled restricted share units were canceled immediately prior to the Effective Time of the Merger and converted into the right to receive an amount in cash determined by multiplying: (i) the Merger Consideration by (ii) the number of shares of Common Stock subject to the restricted share unit award (less applicable tax withholdings). Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 21:37 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Disposition to issuerCommon Stock | 54,640 | $25.00 | $1,366,000.00 |
DisclosureSEC source: 0001606498-26-000108 · wk-form4_1785274657.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Pursuant to the Agreement and Plan of Merger, dated as of April 13, 2026 (as it has been or may be amended, supplemented, waived or otherwise modified in accordance with its terms, the Merger Agreement), by and among the Issuer, A-AV Holdco I, Inc., a Delaware corporation, and A-AV MergerSub, Inc. (Parent), a Delaware corporation and a wholly-owned subsidiary of Parent, each share of the Issuer's common stock, par value $0.01 per share, that was issued and outstanding immediately prior to the effective time of the merger (the Merger), which occurred on July 27, 2026, was converted into and exchanged for the right to receive $25.00 per share in cash, without interest (the Merger Consideration), payable in accordance with the terms and subject to the conditions of the Merger Agreement. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:15 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 754 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001248039-26-000002 · form4-05142026_040502.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,347 F1 · kind: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| May 08, 2026 Filed May 12, 2026 15:37 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantRestricted Share Units · Derivative | 12,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-26-000073 · wk-form4_1778600239.xml · derivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,003 Underlying: Common Stock · 12,003 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025. F2 · derivative.exercise_date: The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors. F2 · derivative.expiration_date: The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:15 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 892 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-013109 · form4-05152025_040501.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,593 F1 · kind: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 18:48 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 12,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-25-000010 · wk-form4_1736189277.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,643 F1 · shares: Represents restricted share units issued to the Reporting Person on January 2, 2025 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:15 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 998 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-013324 · form4-05162024_040507.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,701 F1 · kind: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 20:08 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 8,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-24-000010 · wk-form4_1704398886.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,640 F1 · shares: Represents restricted share units issued to the Reporting Person on January 3, 2024 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Read SEC document |
| May 09, 2023 Filed May 11, 2023 20:15 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 1,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-007810 · form4-05112023_040501.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,703 F1 · kind: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX 2019 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 15:01 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 7,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-23-000008 · wf-form4_167293088592397.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,262 F1 · shares: Represents restricted share units issued to the Reporting Person on January 3, 2023 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:38 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 2,882 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002981 · edgar.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,933 F1 · kind: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 22:36 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 5,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-22-000009 · wf-form4_164133577488892.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,254 F1 · shares: Represents restricted share units issued to the reporting person on January 3, 2022 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:53 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | PurchaseCommon Stock | 800 | $31.67 | $25,336.00 |
DisclosureSEC source: 0001606498-21-000050 · wf-form4_163181840992961.xml · nonDerivative · entry 4 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,900 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:53 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | PurchaseCommon Stock | 900 | $31.65 | $28,485.00 |
DisclosureSEC source: 0001606498-21-000050 · wf-form4_163181840992961.xml · nonDerivative · entry 3 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,100 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:53 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | PurchaseCommon Stock | 853 | $31.62 | $26,971.86 |
DisclosureSEC source: 0001606498-21-000050 · wf-form4_163181840992961.xml · nonDerivative · entry 2 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,200 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:53 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | PurchaseCommon Stock | 2,447 | $31.61 | $77,349.67 |
DisclosureSEC source: 0001606498-21-000050 · wf-form4_163181840992961.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 Read SEC document |
| May 11, 2021 Filed May 13, 2021 23:21 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 2,068 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-005300 · edgar.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,051 F1 · kind: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 15:29 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 4,005 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-21-000007 · wf-form4_160994693275760.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,900 F1 · shares: Represents restricted share units issued to the reporting person on January 4, 2021 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Read SEC document |
| May 14, 2020 Filed May 18, 2020 20:33 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 3,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-006212 · edgar.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,983 F1 · kind: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 8, 2020 21:20 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 5,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-20-000007 · wf-form4_157851843129109.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,895 F1 · shares: Represents restricted share units issued to the reporting person on January 2, 2020 pursuant to the Avanos Medical, Inc. Outside Director's Compensation Plan. Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:15 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 3,963 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-006004 · edgar.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,042 F1 · kind: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX Corporation 2019 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 14:40 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 4,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-19-000007 · wf-form4_154661278426031.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,602 F1 · shares: Represents restricted share units issued to the reporting person on January 2, 2019, pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:16 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 3,887 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-007015 · edgar.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,079 F1 · kind: Grant of restricted stock units under the SPX Corporation 2002 Stock Compensation Plan. F1 · price: Grant of restricted stock units under the SPX Corporation 2002 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| May 03, 2018 Filed May 4, 2018 14:37 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantCommon Stock | 384 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-18-000040 · wf-form4_152544459094785.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,354 F1 · shares: Represents restricted share units issued to the reporting person on May 3, 2018 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:53 UTC | PULTEGROUP INC/MI/ PHM · Entity 3207 | Exercise / conversionDirector Stock Options (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $8.85 | $0.00 |
DisclosureSEC source: 0001127602-18-008112 · form4.xml · derivative · entry 6 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2019-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:53 UTC | PULTEGROUP INC/MI/ PHM · Entity 3207 | Exercise / conversionDirector Stock Options (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $11.93 | $0.00 |
DisclosureSEC source: 0001127602-18-008112 · form4.xml · derivative · entry 5 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:53 UTC | PULTEGROUP INC/MI/ PHM · Entity 3207 | SaleCommon Stock | 4,116 | $30.03 | $123,620.77 |
DisclosureSEC source: 0001127602-18-008112 · form4.xml · nonDerivative · entry 4 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,010 F1 · price: The price reported is an average weighted price. These shares were sold in multiple transactions at prices ranging from $29.59 to $30.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:53 UTC | PULTEGROUP INC/MI/ PHM · Entity 3207 | Exercise / conversionCommon Stock | 7,000 | $8.85 | $61,915.00 |
DisclosureSEC source: 0001127602-18-008112 · form4.xml · nonDerivative · entry 3 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:53 UTC | PULTEGROUP INC/MI/ PHM · Entity 3207 | SaleCommon Stock | 4,561 | $30.03 | $136,985.99 |
DisclosureSEC source: 0001127602-18-008112 · form4.xml · nonDerivative · entry 2 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,126 F1 · price: The price reported is an average weighted price. These shares were sold in multiple transactions at prices ranging from $29.59 to $30.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 22:53 UTC | PULTEGROUP INC/MI/ PHM · Entity 3207 | Exercise / conversionCommon Stock | 7,000 | $11.93 | $83,475.00 |
DisclosureSEC source: 0001127602-18-008112 · form4.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 22:05 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantCommon Stock | 2,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-18-000006 · wf-form4_151501708996195.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,970 F1 · shares: Represents restricted share units issued to the reporting person on January 2, 2018 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan. Read SEC document |
| May 08, 2017 Filed May 10, 2017 22:04 UTC | SPX Technologies, Inc. SPXC · Entity 3543 | GrantCommon Stock | 4,810 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-007017 · edgar.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,192 F1 · kind: Grant of restricted stock pursuant to SPX Corporation 2002 Stock Compensation Plan. F1 · price: Grant of restricted stock pursuant to SPX Corporation 2002 Stock Compensation Plan. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| May 02, 2017 Filed May 4, 2017 23:24 UTC | PULTEGROUP INC/MI/ PHM · Entity 3207 | GrantDeferred Share Unit · Derivative | 6,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016935 · form4.xml · derivative · entry 2 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,264 Underlying: Common Stock · 6,264 shares Expires not disclosed F1 · derivative.exercise_price: Granted under the PulteGroup, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_price: The units will convert into shares of the Company's common stock on a 1-for-1 basis. F3 · derivative.exercise_date: The date exercisable and expiration date are both the date of the Director's termination of Board membership. F3 · derivative.expiration_date: The date exercisable and expiration date are both the date of the Director's termination of Board membership. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 14:35 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantCommon Stock | 3,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001606036-17-000003 · primary_doc.xml · nonDerivative · entry 1 OLEARY PATRICK J · CIK 0001248039 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,024 F1 · shares: Represents restricted share units issued to the reporting person on January 3, 2017 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.